New
HealthMore in Health→
Large gaps in Europe’s trial registry raise new transparency concerns
Key Takeaways
- An analysis found fewer than half of studies reported results on time.
- The finding concerns a major European clinical trial database.
- Delayed reporting weakens transparency and public accountability.
- The result raises questions about compliance and enforcement.
DE
DT Editorial Team··via statnews.com